CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+18.11%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$514M
AUM Growth
+$169M
(+49%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
22.65%
Top 10 Holdings %
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$6.46M |
| 3 |
Gilead Sciences
GILD
|
+$6.38M |
| 4 |
Amgen
AMGN
|
+$6.24M |
| 5 |
Adobe
ADBE
|
+$5.19M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$5.18M |
| 2 |
Analog Devices
ADI
|
+$3.75M |
| 3 |
Amazon
AMZN
|
+$3.48M |
| 4 |
lululemon athletica
LULU
|
+$3.4M |
| 5 |
iQIYI
IQ
|
+$1.91M |
Sector Composition
| 1 | Technology | 34.39% |
| 2 | Healthcare | 30.05% |
| 3 | Consumer Discretionary | 17.55% |
| 4 | Communication Services | 6.11% |
| 5 | Consumer Staples | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Autodesk
ADSK
$69B
| $103K | 0.02% |
425
-372
| -47% | -$90.6K |
|
277
4D Molecular Therapeutics
FDMT
$319M
| $100K | 0.02% |
4,951
+3,873
| +359% | +$78.5K |
|
278
Maravai LifeSciences
MRVI
$367M
| $100K | 0.02% |
15,292
+11,901
| +351% | +$78K |
|
279
Prime Medicine
PRME
$690M
| $99.7K | 0.02% |
+11,258
| New | +$99.7K |
|
280
Amphenol
APH
$141B
| $99.3K | 0.02% |
2,000
| – | – |
|
281
RAPT Therapeutics
RAPT
$222M
| $98.9K | 0.02% |
498
+387
| +349% | +$76.9K |
|
282
89bio
ETNB
$1.28B
| $97.7K | 0.02% |
8,747
+6,802
| +350% | +$76K |
|
283
Arcturus Therapeutics
ARCT
$473M
| $97.4K | 0.02% |
3,089
+2,406
| +352% | +$75.9K |
|
284
Microchip Technology
MCHP
$34.8B
| $96.7K | 0.02% |
1,072
-956
| -47% | -$86.2K |
|
285
Editas Medicine
EDIT
$245M
| $95.7K | 0.02% |
9,450
+7,355
| +351% | +$74.5K |
|
286
Dyne Therapeutics
DYN
$1.88B
| $94.4K | 0.02% |
7,099
+5,541
| +356% | +$73.7K |
|
287
EyePoint Pharmaceuticals
EYPT
$948M
| $94.4K | 0.02% |
+4,085
| New | +$94.4K |
|
288
TJX Companies
TJX
$155B
| $93.8K | 0.02% |
1,000
| – | – |
|
289
Ross Stores
ROST
$48.6B
| $93.7K | 0.02% |
677
-592
| -47% | -$81.9K |
|
290
Copart
CPRT
$46.5B
| $93.6K | 0.02% |
1,910
-1,648
| -46% | -$80.8K |
|
291
Keurig Dr Pepper
KDP
$37.7B
| $93.3K | 0.02% |
2,800
-2,407
| -46% | -$80.2K |
|
292
Sana Biotechnology
SANA
$757M
| $93K | 0.02% |
22,800
+17,753
| +352% | +$72.4K |
|
293
Galapagos
GLPG
$2.16B
| $92.1K | 0.02% |
2,265
+1,770
| +358% | +$72K |
|
294
Regenxbio
RGNX
$482M
| $91.4K | 0.02% |
5,093
+3,968
| +353% | +$71.2K |
|
|
ICVX
295
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $91.3K | 0.02% |
+5,793
| New | +$91.3K |
|
296
Kraft Heinz
KHC
$31.6B
| $90.7K | 0.02% |
2,453
-2,124
| -46% | -$78.5K |
|
|
RVNC
297
DELISTED
Revance Therapeutics, Inc.
RVNC
| $89.3K | 0.02% |
10,155
+7,905
| +351% | +$69.5K |
|
298
Olema Pharmaceuticals
OLMA
$511M
| $89K | 0.02% |
+6,341
| New | +$89K |
|
299
Anavex Life Sciences
AVXL
$862M
| $88.4K | 0.02% |
9,498
+7,395
| +352% | +$68.8K |
|
300
Old Dominion Freight Line
ODFL
$31.2B
| $87.6K | 0.02% |
432
-382
| -47% | -$77.4K |
|